Changes in body composition after 9 months of treatment with exenatide twice daily versus glimepiride: comment letter on Jendle et al.
Gallwitz
B
B
Haupt
A
A
Kraus
P
P
Peters
N
N
Petto
H
H
Dotta
F
F
Petto
H
H
Poll
L
L
Rose
L
L
Schernthaner
G
G
D001823:Body Composition; D001835:Body Weight / Q000187:drug effects*; D003692:Delayed-Action Preparations; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D000077270:Exenatide; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D010455:Peptides / Q000008:administration & dosage*; D013453:Sulfonylurea Compounds / Q000627:therapeutic use*; D014688:Venoms / Q000008:administration & dosage*
D003692:Delayed-Action Preparations; D007004:Hypoglycemic Agents; D010455:Peptides; D013453:Sulfonylurea Compounds; D014688:Venoms; C057619:glimepiride; D000077270:Exenatide